Literature DB >> 15120186

Regulation of FasL expression in natural killer cells.

Hui Lin Chua1, Youri Serov, Zacharie Brahmi.   

Abstract

Fas ligand (FasL)-mediated cytotoxicity is initiated in natural killer (NK) cells through ligation of their activating receptors. The CD16 receptor has been shown to induce FasL expression and cytotoxicity in NK cells. In this study, we made the novel observation that FasL expression was upregulated in NKL cells stimulated through 2B4 and LFA-1 activating receptors, implying a role for FasL-mediated cytotoxicity early in the immune response. Coligation with CD94/NKG2A human leukocyte antigen (HLA) class I inhibitory receptor did not block the induced FasL expression; therefore, these opposing pathways appear to function independently. We also showed, however, that FasL-mediated cytotoxicity was downregulated in CD94/NKG2A-expressing LAK cells in response to the HLA-E ligand, suggesting a mechanism by which aberrant cells expressing class I may evade FasL-mediated cytotoxicity. Thus we show for the first time that 2B4, LFA-1, and CD94/NKG2A receptors are involved in modulating FasL expression and, therefore, cytotoxicity mediated by NK cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120186     DOI: 10.1016/j.humimm.2004.01.004

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  10 in total

1.  Effect of the disintegrin eristostatin on melanoma-natural killer cell interactions.

Authors:  Stefan Hailey; Elizabeth Adams; Ryan Penn; Alice Wong; Mary Ann McLane
Journal:  Toxicon       Date:  2012-11-09       Impact factor: 3.033

Review 2.  Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.

Authors:  Joachim Koch; Michael Tesar
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

Review 3.  Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Authors:  Tin Kyaw; Karlheinz Peter; Yi Li; Peter Tipping; Ban-Hock Toh; Alex Bobik
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

4.  Human NK cells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacity.

Authors:  Catarina R Almeida; Amit Ashkenazi; Gitit Shahaf; Deborah Kaplan; Daniel M Davis; Ramit Mehr
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

Review 5.  Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.

Authors:  Locke D Uppendahl; Carly M Dahl; Jeffrey S Miller; Martin Felices; Melissa A Geller
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

6.  Mechanical suppression of breast cancer cell invasion and paracrine signaling to osteoclasts requires nucleo-cytoskeletal connectivity.

Authors:  Xin Yi; Laura E Wright; Gabriel M Pagnotti; Gunes Uzer; Katherine M Powell; Joseph M Wallace; Uma Sankar; Clinton T Rubin; Khalid Mohammad; Theresa A Guise; William R Thompson
Journal:  Bone Res       Date:  2020-11-17       Impact factor: 13.567

Review 7.  NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy.

Authors:  Wei Wang; Amy K Erbe; Jacquelyn A Hank; Zachary S Morris; Paul M Sondel
Journal:  Front Immunol       Date:  2015-07-27       Impact factor: 7.561

8.  The impact of ageing on natural killer cell function and potential consequences for health in older adults.

Authors:  Jon Hazeldine; Janet M Lord
Journal:  Ageing Res Rev       Date:  2013-05-06       Impact factor: 10.895

9.  Black Raspberries Enhance Natural Killer Cell Infiltration into the Colon and Suppress the Progression of Colorectal Cancer.

Authors:  Pan Pan; Siwen Kang; Youwei Wang; Ka Liu; Kiyoko Oshima; Yi-Wen Huang; Jianying Zhang; Martha Yearsley; Jianhua Yu; Li-Shu Wang
Journal:  Front Immunol       Date:  2017-08-16       Impact factor: 7.561

10.  Novel Application of Radotinib for the Treatment of Solid Tumors via Natural Killer Cell Activation.

Authors:  Kyung Eun Kim; Sunyoung Park; Soyoung Cheon; Dong Yeon Kim; Dae Jin Cho; Jeong Min Park; Dae Young Hur; Hyun Jeong Park; Daeho Cho
Journal:  J Immunol Res       Date:  2018-12-31       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.